| Literature DB >> 27917188 |
Ali Noman1, Muhammad Aqeel2, Shuilin He3.
Abstract
Recent developments in genome editing techniques have aroused substantial excitement among agricultural scientists. These techniques offer new opportunities for developing improved plant lines with addition of important traits or removal of undesirable traits. Increased adoption of genome editing has been geared by swiftly developing Clustered regularly interspaced short palindromic repeats (CRISPR). This is appearing as driving force for innovative utilization in diverse branches of plant biology. CRISPR-Cas9 mediated genome editing is being used for rapid, easy and efficient alteration of genes among diverse plant species. With approximate completion of conceptual work about CRISPR-Cas9, plant scientists are applying this genome editing tool for crop attributes enhancement. The capability of this system for performing targeted and efficient modifications in genome sequence as well as gene expression will certainly spur novel developments not only in model plants but in crop and ornamental plants as well. Additionally, due to non-involvement of foreign DNA, this technique may help alleviating regulatory issues associated with genetically modified plants. We expect that prevailing challenges in plant science like genomic region manipulation, crop specific vectors etc. will be addressed along with sustained growth of this genome editing tool. In this review, recent progress of CRISPR-Cas9 technology in plants has been summarized and discussed. We reviewed significance of CRISPR-Cas9 for specific and non-traditional aspects of plant life. It also covers strengths of this technique in comparison with other genome editing techniques, e.g., Zinc finger nucleases, Transcription activator-like effector nucleases and potential challenges in coming decades have been described.Entities:
Keywords: CRISPR; genome editing; novel phenotypes; plants; targeted modifications
Year: 2016 PMID: 27917188 PMCID: PMC5116475 DOI: 10.3389/fpls.2016.01740
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Successful application of CRISPR-Cas9 in different plant species.
| DNA modification type | Plant | Delivery mode | Target(s) | Gene function(s) | Reference |
|---|---|---|---|---|---|
| Gene Knockout: rewriting of host DNA | Stable integration | ||||
| Stable integration | |||||
| Stable integration | |||||
| Protoplasts, Agrobacterium T-DNA(Transient) | At | ||||
| Protoplasts, Agrobacterium T-DNA (Transient) | |||||
| Protoplasts | |||||
| Stable integration | |||||
| Stable integration | |||||
| Large deletions: | Protoplasts | ||||
| Gene replacement: | Protoplasts | ||||
| Protoplasts | |||||
| Stable integration | |||||
| Controlling gene expression | Agrobacterium T-DNA (Transient) |
Tabular presentation of comparative attributes of plant genome editing techniques.
| CRISPR/Cas9 | Zinc Finger Nucleases (ZFNs) | Transcription factor like effector nucleases (TALENs) | Reference | |
|---|---|---|---|---|
| Mode of action | It works by inducing double-strand breaks in target DNA or single-strand DNA nicks (Cas9 nickase). | It can induce double-strand breaks in target DNA. | Induces DSBs in target DNA. | |
| Off target effects | These effects can be minimized by selecting unique crRNA sequence. | These have off-target effects. | Off target effects cannot be avoided. | |
| Generation of large scale libraries | YES, this is possible to generate large scale libraries. | Such generation is not possible because it requires customization of protein component for each gene. | Generation of large scale libraries is possible but technically difficult and challenging. | |
| Protein engineering steps | It does not requires protein engineering steps, very simple to test multiple gRNA. | It requires complex to test gRNA. | TALENs need protein engineering steps to test gRNA. | |
| Cloning | Cloning is not necessary. | Cloning is necessary. | It requires cloning. | |
| gRNA production | Any number of gRNA can be produced by | Bit difficult to produce this kind of RNA. | gRNA production is bit difficult to achieve through these effector nucleases. | |
| Methylated DNA cleavage | It can cleave methylated DNA in human cells. This aspect is of special concern for plants as this has not been much explored | Unable to do so. | There are many question marks upon capacity of TALENs to perform methylated DNA cleavage. | |
| Multiplexing | This is main advantage of CRISPR. Several genes can be edited at same time. Only | Highly difficult to achieve this through | Very difficult to obtain multiplexed genes by means of TALENs. Because it needs separate dimeric proteins specific for each target | |
| Structural proteins | TALENs | |||
| Catalytic domain | It has two cleavage domains called RUVC and HNH. | TALENs also have FOKI catalytic domain of restriction endonuclease for DSB generation. | ||
| Mutation rate | Comparatively low mutation rate has been observed. | High mutation rate observed in plants. | Mutation rate is high as compared to CRISPR. | |
| Components | crRNA, Cas9 proteins | Zn-finger domains Non-specific FokI nuclease domain | Zn-finger domains Non-specific FokI nuclease domain | |
| Length of target sequence (bp) | 20–22 | 18–24 | 24–59 | |
| Target recognition efficiency | High | High | High | |
| Level of experiment setup | Easy and very fast procedure of designing for new target site | Complicated procedure of redesigning for each new target site and need for expertise in protein engineering | Relatively easy procedure of designing for each new target site |
Technical limitations in CRISPR-Cas9 application and their effects.
| Pitfall | Reason (s) | Effects | Reference |
|---|---|---|---|
| Off-target effects | Unexpected mutations | ||
| Cas9 codons | Insufficient Cas9 codon optimization | Inefficient translation of Cas9 proteins | |
| Vectors | Mostly CRISPR/Cas9 systems use exogenous promoters for Cas9 and sgRNA expression. Vectors with optimal promoters should be selected. | Improper vectors can stop system proceedings. | |
| Gene homologs | Gene family members may complicate target sequences to be edited. | False editing of target sequence. | |
| Epigenetic factors | DNA methylation or histone modification occurs not in regions with complex DNA compositions, such as those with repetitive sequences. | limit protein binding or RNA pairing |
List of promoters and gene(s) targeted through CRISPR-Cas9 system in different plants.
| Plant | sgRNA Promoter(s) | Cas9 Promoter(s) | Target (s) | Reference |
|---|---|---|---|---|
| TaU6 | 2 × 35S | |||
| TaU6 | Ub1 | |||
| CaMV 35S | CaMV 35S | |||
| OsU6 | Rice Actin1 | |||
| AtU6 | 35DPPDK | |||
| OsU6 | 35S | |||
| CaMVE35S | CaMVE 35S | |||
| MpU6-1 | CaMV 35s and MpEF1α | |||
| AtU6 | 35DPPDK | |||
| AtU6-26 | 2 × 35S | |||
| OsU6 | 35S | |||
| OsU3 | 2 × 35S | |||
| OsU6 | CaMV 35S | |||
| OsU3 | Ub1 | |||
| OsU6-2 | 35S |
Different plasmids with their genes, vectors, and promoters used in CRISPR-Cas9 technique.
| Plasmids | Gene/Insert | Promoter | Vector type | Vector back bone | Purpose | Bacterial resistance | Reference |
|---|---|---|---|---|---|---|---|
| pK7WGF2::hCas9 | hCas9 (Syn) | 35S | Plant expression, CRISPR | pK7WGF2, | Expresses the human codon by using Cas9 with N-terminal GFP tag from the 35S promoter in the plant tissue | Spectinomycin | |
| PHSE401 | zCas9, gRNA scaffold | 35S, AtU6-26p | Plant Expression; plant binary vector | pCambia, | CRISPR/Cas based plant genome editing and gene regulation | Kanamycin | |
| pHEE401E | zCas9, gRNA scaffold | U6-26p | Plant Expression; plant binary vector, CRISPR | pCambia | Contain gRNA scaffold for insertion of target sequence, Egg cell-specific promoter-controlled expression of 3×FLAG-NLS-zCas9-NLS | Kanamycin | |
| pHSN501 | zCas9D10A, gRNA scaffold (Syn) | AtU6-26p, 2 × 35Sp | CRISPR; Plant expression | pGreen-like binary vector | CRISPR/Cas based plant genome editing and gene regulation; expresses zCas9D10A | Kanamycin and Spectinomycin | |
| pBUN501 | gRNA scaffold (Syn), zCas9D10A (Syn) | AtU6-26p, Ubi1p, | Plant expression, CRISPR | pGreen-like binary vector | CRISPR/Cas based plant genome editing and gene regulation; | Kanamycin and Spectinomycin | |
| pHSN6A01 | gRNA scaffold (Syn),dCas9-VP64 (Syn) | AtU6-26p, 2 × 35Sp, | Plant expression, CRISPR | pGreen-like binary vector | expresses dCas9-VP64, gRNA scaffold for insertion of target sequence | Kanamycin and Spectinomycin | |
| pBUN6A11 | gRNA scaffold (Syn), dCas9-VP64 (Syn), | OsU3p, Ubi1p, | Plant expression, CRISPR | pGreen-like binary vector | expresses dCas9-VP64, gRNA scaffold for insertion of target sequence | Kanamycin and Spectinomycin | |
| pEGB 35s:dCas:BRD:tNos (GB1172) | dCas9:BRD | 35S | Plant expression, CRISPR | pDGB3alpha2 | Transcriptional unit of (human codon optimized) inactivated Cas9 fused to the BRD Transcriptional Repressor | Kanamycin | |
| pEGB 35S:dCas9:Tnos (GB1191) | dCas9 | 35S | Plant Expression, CRISPR, Synthetic Biology | pDGB3alpha2 | Transcriptional unit for human codon optimized with mutated (D10A, H840A) and inactivated catalytic domains Cas9 protein plant expression driven by the 35S promoter | Kanamycin | |
| pJIT163-2NLSCas9 | dCas9 | 2 × 35S | Plant Expression | pJIT163 | Expression of rice codon-optimized Cas9 in plant cells | Ampicillin | |
| HBT-pcoCas9 | Pro Cas9 (syn) | Hybrid constitutive promoter 35SPPDK | CRISPR; Plant expression | HBT-FLAG | Transient expression of pcoCas9 gene in plant cells | Ampicillin |
Specific commercial products and services available to the researchers to implement CRISPR technology.
| Commercial sources | Products and services | |||
|---|---|---|---|---|
| Genome-wide sgRNA clones | HDR donor cloning vectors and custom HDR donor construction. | Cas9 stable cell lines. | Insertion/deletion detection system | |
| CRISPR Selection Too | Paired nickases | Codon-optimized Cas9 | Transfection-grade CRISPR plasmid with a guide RNA | |
| Q5 Hot Start High-Fidelity 2X Master Mix, NEBuilder HiFi DNA Assembly Master Mix | Q5 Site-Directed Mutagenesis Kit (with competent cells) and Q5 Site-Directed Mutagenesis Kit (Without Competent Cells) | EnGe Cas9 Nuclease | EnGen Mutation Detection Kit | |
| Human HPRT PCR Primer Mix, Mouse HPRT PCR Primer Mix, Nuclease Free Duplex Buffer | S.p. Cas9 Expression Plasmid | S.p. Cas9 Nuclease 3NLS (100, 500 μg) | CRISPR Negative Control crRNA, CRISPR Positive Control crRNA | |
| Nickase Ninja All-in-One construct expressing specific dual gRNAs | Electra Cloning Kit | |||
| ROSA26 large fragment knockin | ||||
| CRISPR/Cas starter kit (HA tagging human HSP60 at C-terminus). | pCas-Guide-Nickase (D10A), pT7-Cas9-Nickase (D10A) | pCas-Guide Cloning Kit, | pCas-Guide-scramble (also available as negative control) | |
| Multiplex gRNA Cloning Kit Create CRISPR/Cas9 constructs with multiple gRNAs simultaneously for better genome editing | ||||
| Cloning Oligos | Indel Detection by Amplicon Analysis | Custom Sequencing (Check the sequence of your CRISPR plasmid or genomic target sequence) | ||